Published in

American Society for Microbiology, Microbiology Spectrum, 1(11), 2023

DOI: 10.1128/spectrum.02376-22

Links

Tools

Export citation

Search in Google Scholar

Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population

Journal article published in 2023 by Larissa Fernandes-Matano ORCID, Angel Gustavo Salas-Lais ORCID, Concepción Grajales-Muñiz ORCID, Mauricio Hernández-Ávila ORCID, Yonathan Omar Garfias-Becerra ORCID, Mario César Rodríguez-Sepúlveda ORCID, Carlos Segura-Sánchez ORCID, Daniel Montes-Herrera, Denisse Mendoza-Sánchez, Javier Angeles-Martínez ORCID, Andrea Santos Coy-Arechavaleta ORCID, Julio Elías Alvarado-Yaah ORCID, Clara Esperanza Santacruz-Tinoco ORCID, Eva Ramón-Gallegos ORCID, José Esteban Muñoz-Medina ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Since the start of the vaccination programs against COVID-19 in 2020, it was evident that due to global shortages, the demand for the dose required in Mexico could only be covered by acquiring different vaccines. Therefore, determining the effectiveness of these and the longevity of acquired immunity is extremely important in a scenario where SARS-CoV-2 circulation becomes endemic and booster doses are required periodically.